FATE THERAPEUTICS INC

By person

23 insiders · 387 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Redmile Group, LLC entity

Director

$135.69M (9)

$2.34M (2)

+$133.35M

38,801,402

32.38%

$95.44M

+20.5%

Wolchko J Scott

President and CEO

—

$49.07M (80) scheduled

−$49.07M

371,248

0.3098%

$913.20K

+161.4%

TAHL CINDY

See Remarks

—

$28.74M (65) scheduled

−$28.74M

589,355

0.4919%

$1.45M

+1,001%

Nashat Amir

Director

—

$22.96M (84)

−$22.96M

11,034

0.0092%

$27.14K

−99.2%

Valamehr Bahram

President and CEO

—

$14.35M (55) scheduled

−$14.35M

591,815

0.4939%

$1.46M

+659.1%

Shoemaker Daniel D

Chief Scientific Officer

—

$6.63M (29)

−$6.63M

73,020

0.0609%

$179.61K

−29.7%

Dulac Edward J III

Chief Financial Officer

—

$2.88M (17) scheduled

−$2.88M

101,479

0.0847%

$249.62K

—

Chu Yu-Waye

Chief Medical Officer

—

$1.05M (16)

−$1.05M

140,676

0.1174%

$346.03K

+106.6%

RASTETTER WILLIAM H

Director

$1,000.00K (1)

—

+$1,000.00K

642,424

0.5362%

$1.58M

+218.5%

MENDLEIN JOHN

Director

$698.14K (2)

$1.14M (3) scheduled

−$438.15K

311,231

0.2597%

$765.57K

+110.1%

Coughlin Timothy

Director

$150.00K (1)

$32.82K (1)

+$117.17K

9,892

0.0083%

$24.33K

—

Plavsic Mark

Chief Technical Officer

—

$109.43K (2)

−$109.43K

123,705

0.1032%

$304.29K

—

Storgard Chris

Chief Medical Officer

$100.00K (1)

—

+$100.00K

46,683

0.0390%

$114.83K

+413.6%

Agarwal Shefali

Director

—

$36.81K (2)

−$36.81K

10,490

0.0088%

$25.80K

+1,200%

Jooss Karin

Director

—

$33.84K (1)

−$33.84K

9,848

0.0082%

$24.22K

—

Xu Yuan

Director

—

$24.33K (3) scheduled

−$24.33K

8,669

0.0072%

$21.32K

—

Powl Brian T.

Chief Commercial Officer

—

$18.77K (1)

−$18.77K

41,146

0.0343%

$101.21K

—

HERSHBERG ROBERT

Director

—

$15.29K (1)

−$15.29K

10,659

0.0089%

$26.22K

—

Bressi Jerome Charles

See Remarks

—

$9.27K (1)

−$9.27K

335,203

0.2798%

$824.53K

+21.4%

Adawi Kamal

Chief Financial Officer

—

100,000

0.0835%

$245.98K

—

ABBOT STEWART

Chief Development Officer

—

64,917

0.0542%

$159.68K

+48.0%

EPSTEIN ROBERT S

Director

—

36,331

0.0303%

$89.37K

—

Lee Michael Stewart

Director

—

11,331

0.0095%

$27.87K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

TAHL CINDY

6 May 2026

See Remarks

Exercised, kept

44,444

$1.05

$46.67K

TAHL CINDY

6 May 2026

See Remarks

Exercised, kept

122,220

$1.32

$161.33K

RASTETTER WILLIAM H

5 May 2026

Director

Exercised, kept

25,000

$1.69

$42.25K

EPSTEIN ROBERT S

5 May 2026

Director

Exercised, kept

25,000

$1.69

$42.25K

MENDLEIN JOHN

19 Jan 2023

Director

Exercised, kept

28,461

$1.37

$38.99K

Valamehr Bahram

12 Jan 2023

Chief R&D Officer

Exercised, kept

423

$1.37

$579.51

Showing 250 of 387 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out